The BioPharma Industry’s Unrealized Wealth of Data

The BioPharma Industry’s Unrealized Wealth of Data

Wednesday, June 21, 2017

Ben Szekely, VP of Solutions and Pre-sales at Cambridge Semantics, writes in this article for the Leaders in Pharmaceutical Business Intelligence (LPBI) Group how ‘Smart’ Patient Data Lakes (SPDL) help biopharma researchers take greater advantage of the ever-growing volumes of patient data.

The full article can be found here.